• Home
  • Technology
  • Gaming
  • Entertainment
  • World & Business
  • Science
  • Sports
  • AI
HomeTechnologyGamingEntertainmentWorld & BusinessScienceSportsAI
    • HomeTechnologyGamingEntertainmentWorld & BusinessScienceSportsAI
    • Home
    • Technology
    • Gaming
    • Entertainment
    • World & Business
    • Science
    • Sports
    • AI
    AI
    Announcement

    ChronicleBio aims to use AI to find treatments for POTS and long COVID

    Forbes reports that a former OpenAI executive started the company to study chronic diseases using AI and biological data.

    FS
    2 Sources, 9h ago, first seen 9h ago

    TLDR

    Forbes reports that a former OpenAI executive started ChronicleBio to search for treatments for POTS and long COVID. A founder says the company plans to build a dataset on those and other conditions to investigate the biology behind symptoms and match drugs to patients.

    Combined views

    29.6K

    2 Sources, first seen 9h ago

    likes

    Combined views

    29.6K

    2 Sources, first seen 9h ago

    350 likes
    350
    37 comments
    96 saves
    40 reposts

    Sentiment

    Positive——Negative

    Summary

    Not enough discussion yet.

    No sentiment analysis available yet.

    Featured Source
    37 comments
    96 saves
    40 reposts

    Sentiment

    Positive——Negative

    Summary

    Not enough discussion yet.

    No sentiment analysis available yet.

    Today's Rank

    —

    Not ranked yet

    Today's Rank

    —

    Not ranked yet

    2 Sources

    @fidjissimoThanks @Forbes for featuring the great work we’re doing @ChronicleBioAI. There are exactly 0 FDA-approved therapies for the hundreds of millions of people suffering from diseases like POTS, Long COVID, MECFS or hEDS. We created ChronicleBio to change this. By building the deepest dataset on these conditions and leveraging AI, we will understand what the biology behind the symptoms is. From there, we can map the right drugs to the right patients.

    2 Sources

    @fidjissimoThanks @Forbes for featuring the great work we’re doing @ChronicleBioAI. There are exactly 0 FDA-approved therapies for the hundreds of millions of people suffering from diseases like POTS, Long COVID, MECFS or hEDS. We created ChronicleBio to change this. By building the deepest dataset on these conditions and leveraging AI, we will understand what the biology behind the symptoms is. From there, we can map the right drugs to the right patients.